News | Women's Health | July 21, 2015

North Carolina State University researcher finds celebrity influence had major impact on screening decisions, even above family history

breast cancer screening, Angelina Jolie, Kami Kosenko, North Carolina State

July 21, 2015 Angelina Jolie received widespread media attention in 2013 when she told the public that she'd tested positive for BRCA1, a gene associated with an increased risk of breast and ovarian cancers. Now research shows that this publicity did influence some women's intentions to seek out similar genetic testing.

"We put a questionnaire online within three days of Jolie's announcement, to see if the announcement influenced anyone's intention to get genetic testing," said Kami Kosenko, an associate professor of communication at North Carolina State University and lead author of a paper on the work. "We also wanted to see if there were any variables, such as whether people felt they identified with Jolie, that were associated with people who were influenced by Jolie's announcement."

Three hundred and fifty-six people from across the United States completed the questionnaire, of which 295 were aware of Jolie's announcement and double mastectomy.

Of the 229 female study participants, researchers found that 30 percent intended to get tested to see if they carried the BRCA1 gene, with 23 percent saying they would probably get tested and 7 percent saying they would definitely get tested.

"Women who identified more strongly with Jolie were more likely to intend to get the genetic testing regardless of whether they had a family history of cancer than women who did have a family history of cancer but did not identify with Jolie," Kosenko said. "The same was true of women who felt they had some sort of parasocial relationship with Jolie, meaning they viewed her as a friend. This means that Jolie's speaking out definitely had an impact."

The findings suggest that when it comes to a celebrity's impact on the public, that impact depends in part on the extent to which the public identifies with the celebrity. In other words, there appears to be something about particular celebrities that engenders more public interest and concern.

"This indicates that health practitioners and advocates may want to consider how relatable a celebrity is with the target audience when searching for a celebrity spokesperson," Kosenko said. "However, more work needs to be done to help us understand what makes a celebrity relatable. For example, in our survey, non-white women were more likely to identify with Jolie than white women were. Why is that? We don't know."

The paper, "Celebrity Influence and Identification: A Test of the Angelina Effect," was published online in the Journal of Health Communication.

For more information: www.ncsu.edu


Related Content

News | FDA

Dec. 8, 2025 — Lunit, a provider of AI for cancer diagnostics and precision oncology, has submitted a 510(k) premarket ...

Time December 08, 2025
arrow
News | Breast Imaging

Dec. 01, 2025 — DeepHealth, a wholly owned subsidiary of RadNet, Inc., has launched the DeepHealth Breast Suite,2 an end ...

Time December 04, 2025
arrow
News | Women's Health

Dec. 1, 2025 — ScreenPoint Medical has completed a commercial agreement making its Transpara breast-imaging AI portfolio ...

Time December 03, 2025
arrow
News | Mammography

Nov. 30, 2025 — At RSNA 2025, Siemens Healthineers will introduce new capabilities for its Mammomat B.brilliant ...

Time December 02, 2025
arrow
News | RSNA 2025

Dec. 2, 2025 — Lunit, a provider of AI for cancer diagnostics and precision oncology, will present 14 studies at RSNA ...

Time December 02, 2025
arrow
News | Women's Health

Dec. 1, 2025 — A study of data from seven outpatient facilities in the New York region found that 20-24% of all the ...

Time December 02, 2025
arrow
News | Mammography

Nov. 26, 2025 — GE HealthCare has announced it received FDA Premarket Authorization for Pristina Recon DL, an advanced ...

Time November 29, 2025
arrow
News | Artificial Intelligence

Nov. 25, 2025 – Medical imaging AI company Avicenna.AI has announced a strategic partnership with Ferrum, an AI ...

Time November 25, 2025
arrow
News | Ultrasound Imaging

Nov. 12, 2025 — GE HealthCare and DeepHealth, Inc., a wholly owned subsidiary of RadNet, Inc., have announced their ...

Time November 20, 2025
arrow
News | Breast Imaging

Nov. 17, 2025 — RadNet, Inc. and its wholly owned subsidiary, DeepHealth have announced results from the largest real ...

Time November 17, 2025
arrow
Subscribe Now